from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3841/bfrB

LFCtreatmentdescriptionclass of inhibitor

1.483

Amikacinug/mL Amikacintranslation

0.836

Cap5-10ug/mL Capreomycintranslation

0.652

Rox10-50 ug/mL Roxithromycintranslation

0.913

SM2-5 ug/mL Streptomycintranslation

1.236

Tet5-10 ug/mL Tetracyclinetranslation

-0.988

Rif0.2-5ug/mL Rifampicintranscription

-0.090

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.293

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.299

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.798

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.861

Clofazimine10-13 ug/mL Clofaziminerespiration

0.055

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.440

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.370

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.547

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.161

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.629

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.554

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.234

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.164

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.109

KCN5-20 ug/mL Potassium cyaniderespiration

0.689

NaN30.2-2 mM Sodium aziderespiration

0.955

Nigericin50 uM Nigericinrespiration

-0.851

TRC10-150 ug/mL Triclosanrespiration

-0.038

TRZ10-25 ug/mL Thioridazinerespiration

-0.754

Valinomycin0.5-10 uM Valinomycinrespiration

-0.159

ZnSO42 mM ZnSO4respiration

-0.590

menadione6-10 ug/mL Menadionerespiration

-1.453

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.421

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-2.570

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.040

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.760

NRP_1Non-replicating persistence stage 1dosRassociated

-0.008

Amp0.2mg/mL AmpicillincellWall

0.069

Cephalexin20-100 ug/mL CephalexincellWall

0.040

Cerulenin0.32-5 ug/mL CerulenincellWall

0.419

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.041

EMB10-20 ug/mL EthambutolcellWall

0.259

Eta12-40 ug/mL EthionamidecellWall

0.367

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.267

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.817

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.667

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.717

BZA0.12 mg/mL BenzamidearomaticAmides

1.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.126

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.921

H2O24 mM hydrogen peroxideDNAdamaging

0.680

Levo10 ug/mL LevofloxacinDNAdamaging

-0.155

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.259

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.500

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.264

UVUV-irradiationDNAdamaging

-0.675

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.043

Antimycin12.5-50 ug/mL Antimycin A?

0.026

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.312

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.219

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.018

PA8240.2-2 ug/mL PA-824?

0.360

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.057

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.086

Verapamil50 uM Verapamil?

-0.014

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.041

methoxatin10-20 ug/mL Methoxatin?